These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7837229)

  • 21. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K; Kotthaus J; Khadembashi L
    Arch Pharm (Weinheim); 2009 Jan; 342(1):27-33. PubMed ID: 19051198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J; Kuusisto A; van Bruchem J; Patel JZ; Laitinen T; Navia-Paldanius D; Laitinen JT; Savinainen JR; Parkkari T; Nevalainen TJ
    Bioorg Med Chem; 2014 Dec; 22(23):6694-6705. PubMed ID: 25282655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipophilicity-related inhibition of blood platelet aggregation by nipecotic acid anilides.
    De Marco A; De Candia M; Carotti A; Cellamare S; De Candia E; Altomare C
    Eur J Pharm Sci; 2004 Jun; 22(2-3):153-64. PubMed ID: 15158900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic nipecotamide increases cyclic AMP levels and inhibits protein phosphorylation in human platelets.
    Handa RK; Dillingham EO; Gollamudi R
    Life Sci; 1995; 57(10):983-8. PubMed ID: 7643723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiplatelet agents affecting the interaction of Tissue Factor-Factor VIIa complex with Factor X in a continuous-flow reactor.
    Gir S; Reavis R; Turitto VT; Gollamudi R
    Biotechnol Appl Biochem; 1996 Feb; 23(1):63-6. PubMed ID: 8867897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonists.
    Ishikawa M; Kubota D; Yamamoto M; Kuroda C; Iguchi M; Koyanagi A; Murakami S; Ajito K
    Bioorg Med Chem; 2006 Apr; 14(7):2109-30. PubMed ID: 16309912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and identification of chiral aminomethylpiperidine carboxamides as inhibitor of collagen induced platelet activation.
    Anil Kumar KS; Misra A; Siddiqi TI; Srivastava S; Jain M; Bhatta RS; Barthwal M; Dikshit M; Dikshit DK
    Eur J Med Chem; 2014 Jun; 81():456-72. PubMed ID: 24859764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Design, synthesis, and biological evaluation of phenylpropenamides compounds as anti-platelet aggregation].
    Yang Y; Zuo J; Li JM; Ma XD; Zhang YC; Huang WJ
    Yao Xue Xue Bao; 2017 Jan; 52(1):120-5. PubMed ID: 29911807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-substituted 4-isoxazolecarboxamides with platelet antiaggregating and other activities.
    Fossa P; Menozzi G; Schenone P; Filippelli W; Russo S; Lucarelli C; Marmo E
    Farmaco; 1991 Jun; 46(6):789-802. PubMed ID: 1772564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lysergic acid analogs: 5-phenylnicotinamides and nipecotamides.
    Johnson FN; Battista SP; Reid D
    J Pharm Sci; 1973 Nov; 62(11):1881-3. PubMed ID: 4271307
    [No Abstract]   [Full Text] [Related]  

  • 32. Inhibition of agonist-induced rise in platelet Ca2+ by antithrombotic nipecotamides.
    Gollamudi R; Dillingham EO; Bond SE
    Blood Coagul Fibrinolysis; 1994 Jun; 5(3):375-83. PubMed ID: 8075309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid development of piperidine carboxamides as potent and selective anaplastic lymphoma kinase inhibitors.
    Bryan MC; Whittington DA; Doherty EM; Falsey JR; Cheng AC; Emkey R; Brake RL; Lewis RT
    J Med Chem; 2012 Feb; 55(4):1698-705. PubMed ID: 22263917
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, and biological evaluation of novel non-piperazine analogues of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines as dopamine transporter inhibitors.
    Choi SW; Elmaleh DR; Hanson RN; Fischman AJ
    J Med Chem; 1999 Sep; 42(18):3647-56. PubMed ID: 10479296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin efflux-inducing effects on human blood platelets by carbamoylpiperidine and nipecotoylpiperazine aggregation inhibitors.
    Lasslo A; Dillingham EO; Gollamudi R; Carter-Burks G
    Res Commun Chem Pathol Pharmacol; 1987 Oct; 58(1):129-37. PubMed ID: 3432730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design of a new class of orally active fibrinogen receptor antagonists.
    Klein SI; Molino BF; Czekaj M; Gardner CJ; Chu V; Brown K; Sabatino RD; Bostwick JS; Kasiewski C; Bentley R; Windisch V; Perrone M; Dunwiddie CT; Leadley RJ
    J Med Chem; 1998 Jul; 41(14):2492-502. PubMed ID: 9651154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability.
    Dillingham EO; Lasslo A; Gollamudi R; Bond SE; Carter-Burks G
    Res Commun Chem Pathol Pharmacol; 1990 Feb; 67(2):179-99. PubMed ID: 2333408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Piperidine amides as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors.
    Flyrén K; Bergquist LO; Castro VM; Fotsch C; Johansson L; St Jean DJ; Sutin L; Williams M
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3421-5. PubMed ID: 17442567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.